IR-MED Chairman & Interim CEO Issues Letter to Shareholders
21 août 2023 09h15 HE
|
IR-Med, Inc.
Rosh Pina, Israel, Aug. 21, 2023 (GLOBE NEWSWIRE) -- IR-MED Inc., (“IR-MED” or the “Company”) (OTCQB:IRME), developer of a noninvasive AI-driven infrared spectrographic analysis technology platform...
IR-MED’s AI-Powered Infra-Red Spectrographic Decision Support System PressureSafe Device Demonstrates High Efficacy in Detecting Pressure Injuries with 96% Accuracy: Potential to Set a New Standard of Care
17 juil. 2023 09h15 HE
|
IR-Med, Inc.
IR-MED to file for FDA approval Q4 2023 with U.S. market launch expected in H1 20242.5 million patients develop pressure injuries and 60,000 die annually as a direct result; $26.8 billion is spent...
IR-MED Honors Juneteenth with Commitment to Healthcare Equality: PressureSafe Device Sees Beneath the Skin to Address Inequality in Pressure Injuries
12 juin 2023 09h15 HE
|
IR-Med, Inc.
Early detection of pressure injuries can be challenging for minority populations due to the current method of visual inspectionPatients with dark skin tones suffered more than twice as much as those...
IR-Med Appoints Dr. Lynn Eschenbacher to its Advisory Board as Company Advances Toward Launch of its PressureSafe Wound Care Device
07 juin 2023 09h28 HE
|
IR-Med, Inc.
Innovative executive driving positive outcomes and profitability, Dr. Eschenbacher is focused on addressing healthcare access and equityThrough early, non-invasive detection of pressure injuries,...
IR-Med’s PressureSafe Noninvasive Wound Care Device to be Demonstrated at Northwell Health’s 10th Annual Shining the Light on Wound Care Symposium
19 mai 2023 09h15 HE
|
IR-Med, Inc.
A 94.7% accuracy in identifying Stage 1 pressure injuries was achieved in a proof-of-concept device upon which PressureSafe is basedCompany to exhibit and demo its “sense the invisible” handheld...
IR-Med to present at National Pressure Injury Advisory Panel 2023
14 mars 2023 09h00 HE
|
IR-Med, Inc.
The company’s PressureSafe device is being designed to reduce healthcare disparity in pressure injury detection and treatment Rosh Pina, Israel, March 14, 2023 (GLOBE NEWSWIRE) -- “IR-MED” or the...
IR-MED SIGNS AGREEMENT TO EXPAND ITS PRESSURESAFE DEVICE USABILITY STUDY
14 févr. 2023 09h15 HE
|
IR-Med, Inc.
The study will expand to Rabin Medical Center (RMC), in parallel to Beit-Rivka, turning the study to a double center usability study. Rosh Pinna, Israel, Feb. 14, 2023 (GLOBE NEWSWIRE) --...
IR-Med Announces Dr. David Dalton as Advisory Board member
16 nov. 2022 09h32 HE
|
IR-Med, Inc.
Dr. Dalton brings decades of experience as a hall of fame CEO, entrepreneur, pharmaceutical executive and founder of over 40 companies Rosh Pinna, Israel, Nov. 16, 2022 (GLOBE NEWSWIRE) --...
IR-Med Signs Agreement for the Commercial Design of the PressureSafe Device
30 août 2022 09h15 HE
|
IR-Med, Inc.
Rosh Pinna, Israel, Aug. 30, 2022 (GLOBE NEWSWIRE) -- (“IR-MED or the “Company”) (OTCQB:IRME), an innovative medical device company that is developing non-invasive, real-time detection devices...
IR-Med files Provisional Patent Application Covering Additional Features of its PressureSafe Device for Early Detection of Pressure Injuries
12 août 2022 08h34 HE
|
IR-Med, Inc.
Rosh Pinna, Israel, Aug. 12, 2022 (GLOBE NEWSWIRE) -- (“IR-MED or the “Company”) (OTCQB:IRME), an innovative medical device company, developing non-invasive, real-time detection devices that utilize...